Cargando…
CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer
Data describing relationships between the tumor immune microenvironment and patient outcome are limited for esophageal squamous cell cancer (ESCC). The present study investigated the prognostic values of programmed death-ligand 1 (PD-L1) expression and CD8+ or forkhead box protein 3+ (FOXP3+) tumor-...
Autores principales: | Zhu, Yingming, Li, Minghuan, Mu, Dianbin, Kong, Li, Zhang, Jianbo, Zhao, Fen, Li, Zhenxiang, Liu, Xuemei, Bo, Cong, Yu, Jinming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5342092/ https://www.ncbi.nlm.nih.gov/pubmed/27683115 http://dx.doi.org/10.18632/oncotarget.12213 |
Ejemplares similares
-
The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy
por: Liu, Xuemei, et al.
Publicado: (2017) -
Expressions of CD8+TILs, PD-L1 and Foxp3+TILs in stage I NSCLC guiding adjuvant chemotherapy decisions
por: Teng, Feifei, et al.
Publicado: (2016) -
Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation
por: Zhu, Yingming, et al.
Publicado: (2016) -
Timing of Adjuvant Chemoradiation in pT1-3N1-2 or pT4aN1 Esophageal Squamous Cell Carcinoma After R0 Esophagectomy
por: Wu, Leilei, et al.
Publicado: (2020) -
Risk factors for tumor recurrence in patients with pT(3)N(0)M(0) thoracic esophageal squamous cell carcinoma after esophagectomy
por: Feng, Wei, et al.
Publicado: (2020)